Joni Foley
Vendite & Marketing presso Gemini Pharmaceuticals, Inc.
Provenienza dei contatti di primo grado di Joni Foley
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY.
5
| Private Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Joni Foley tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| KINTARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Catania | College/University | Doctorate Degree | |
| University of California | College/University | Corporate Officer/Principal | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| Theia Therapeutics, Inc. | Founder | ||
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Italia | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| President | 1 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Napoleone Ferrara | 8 |
| Andrew Finamore | 1 |
| Michael Finamore | 1 |
| Emma Ebere | 1 |
| John Donovan | 1 |
- Borsa valori
- Insiders
- Joni Foley
- Connessioni Società
